| MolName | (5Z)-3-cyclopentyl-5-[[2-[(2-hydroxy-2-phenylethyl)amino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C25H24N4O3S2 |
| Smiles | OC(CNC(N=C1N2C=CC=C1)=C(/C=C(/C(N1C3CCCC3)=O)\SC1=S)C2=O)c1ccccc1 |
| InChI | InChI=1S/C25H24N4O3S2/c30-19(16-8-2-1-3-9-16)15-26-22-18(23(31)28-13-7-6-12-21(28)27-22)14-20-24(32)29(25(33)34-20)17-10-4-5-11-17/h1-3,6-9,12-14,17,19,26,30H,4-5,10-11,15H2/t19-/m0/s1 |
| InChIK | RQMOQQNXOQFKBS-IBGZPJMESA-N |
| TotalMolweight | 492.623 |
| Molweight | 492.623 |
| MonoisotopicMass | 492.128981 |
| CLogP | 1.2566 |
| CLogS | -5.643 |
| H Acceptors | 7 |
| H Donors | 2 |
| TotalSurfaceArea | 360.77 |
| Relative PSA | 0.31804 |
| PolarSurfaceArea | 142.63 |
| Druglikeness | 3.5527 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.47059 |
| Fragments | 1 |
| Non HAtoms | 34 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| StereoCenters | 1 |
| Rotatable Bond | 6 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 1 |
| Aromatic Atoms | 6 |
| Sp3Atoms | 10 |
| Symmetricatoms | 4 |
| Amides | 2 |
| BasicNitrogens | 1 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (5Z)-3-cyclopentyl-5-[[2-[(2-hydroxy-2-phenylethyl)amino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5Z)-3-cyclopentyl-5-[[2-[(2-hydroxy-2-phenylethyl)amino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one